This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matsumori, Y. Articles by Matsui, T. Search for Related Content PubMed PubMed Citation Articles by Matsumori, Y. Articles by Matsui, T.

Cholecystokinin-B/Gastrin Receptor: A Novel Molecular Probe for Human Small Cell Lung Cancer¹

Third Division, Department of Medicine, Kobe University School of Medicine [Y. M., M. I., T. T., N. I., T. T., K. C., T. M.], 7-5-1, Kusunoki-cho, Chuo-ku, and Kobe City General Hospital [N. K.], Kobe 650, Japan

The brain-gut hormones, gastrin and cholecystokinin, have a trophic effect on the gastrointestinal mucosa in vivo and promote the growth of several neoplastic cell lines. In this study, cholecystokinin-B/gastrin receptor has been demonstrated to provide a novel molecular marker for the diagnosis of small cell lung cancer by using biopsy specimens. Physiological expression of the receptor mRNA is detectable in particular areas of the human brain, stomach, and pancreas but not in the lung. The receptor mRNA was detected selectively in all small cell lung cancer (10 cases) with a RT-PCR assay. By contrast, it was detectable in only 1 of 13 squamous cell carcinomas or 21 adenocarcinomas of the lung. Thus, the cholecystokinin-B/gastrin receptor could be an attractive therapeutic target for small cell lung cancer.

¹ This study was supported in part by Grants-in-Aid for Scientific Research and Cancer Research from the Ministry of Education, Science and Culture, Japan.

² To whom requests for reprints should be addressed.

Received 8/ 2/94. Accepted 11/ 8/94.

This article has been cited by other articles:

				M. Dufresne, C. Seva, and D. Fourmy Cholecystokinin and gastrin receptors. Physiol Rev, July 1, 2006; 86(3): 805 - 847. [Abstract] [Full Text] [PDF]

				S. Schulz, C. Rocken, C. Mawrin, and S. Schulz Immunohistochemical Localization of CCK1 Cholecystokinin Receptors in Normal and Neoplastic Human Tissues J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6149 - 6155. [Abstract] [Full Text] [PDF]

				B. A. Nock, T. Maina, M. Behe, A. Nikolopoulou, M. Gotthardt, J. S. Schmitt, T. M. Behr, and H. R. Macke CCK-2/Gastrin Receptor-Targeted Tumor Imaging with 99mTc-Labeled Minigastrin Analogs J. Nucl. Med., October 1, 2005; 46(10): 1727 - 1736. [Abstract] [Full Text] [PDF]

				J. C. Reubi Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy Endocr. Rev., August 1, 2003; 24(4): 389 - 427. [Abstract] [Full Text] [PDF]

				J.-C. Schaer and J. C. Reubi High Gastrin and Cholecystokinin (CCK) Gene Expression in Human Neuronal, Renal, and Myogenic Stem Cell Tumors: Comparison with CCK-A and CCK-B Receptor Contents J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 233 - 239. [Abstract] [Full Text]